Literature DB >> 7507555

Protein restriction (PR) and caloric restriction (CR) compared: effects on DNA damage, carcinogenesis, and oxidative damage.

L D Youngman1.   

Abstract

Protein restriction (PR) and caloric restriction (CR) similarly impinge upon various physiological factors that can significantly inhibit the growth of DNA-damaged tissue and, therefore, carcinogenesis. Whether this effect is largely, or only in part, due to simple inhibition of body weight gain is examined. Among their many other health-improving effects, PR and CR delay the onset of puberty. It has been suggested that animals have developed mechanisms to cope with lean periods and that, when food is limited, resources are diverted from those physiological functions that offer no benefit for immediate survival (e.g., reproductive capacity) to thereby support an increase in the maintenance functions that prolong life. PR has also been shown to affect numerous other varied mechanisms that can affect carcinogenesis, including gene expression and metabolism of xenobiotics. The effects of PR on initiational and promotional growth of DNA-damaged tissue is also discussed. PR also seems to boost antioxidant defenses and inhibit the accumulation of oxidative damage (as does CR). Protein restricted animals have been shown to accumulate more calories, but develop fewer preneoplastic lesions and tumors than their high-protein counterparts. This observation seems quite counter to most ideas about dietary restrictions and CR. Despite the fact that both PR and CR induce many beneficial physiological effects in common, it is possible that PR is the more feasible option for human consideration. The levels of PR likely to improve health without negative side effects are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507555     DOI: 10.1016/0921-8734(93)90018-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Dietary restriction (DR) and its advantages.

Authors:  M N Astagimath; Shrinivas B Rao
Journal:  Indian J Clin Biochem       Date:  2004-01

2.  Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population.

Authors:  Morgan E Levine; Jorge A Suarez; Sebastian Brandhorst; Priya Balasubramanian; Chia-Wei Cheng; Federica Madia; Luigi Fontana; Mario G Mirisola; Jaime Guevara-Aguirre; Junxiang Wan; Giuseppe Passarino; Brian K Kennedy; Min Wei; Pinchas Cohen; Eileen M Crimmins; Valter D Longo
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

Review 3.  Fasting and Caloric Restriction in Cancer Prevention and Treatment.

Authors:  Sebastian Brandhorst; Valter D Longo
Journal:  Recent Results Cancer Res       Date:  2016

4.  Protein restriction without strong caloric restriction decreases mitochondrial oxygen radical production and oxidative DNA damage in rat liver.

Authors:  Alberto Sanz; Pilar Caro; Gustavo Barja
Journal:  J Bioenerg Biomembr       Date:  2004-12       Impact factor: 2.945

5.  Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.

Authors:  Sebastian Brandhorst; Min Wei; Saewon Hwang; Todd E Morgan; Valter D Longo
Journal:  Exp Gerontol       Date:  2013-02-21       Impact factor: 4.032

6.  Age-associated decreases in human DNA repair capacity: Implications for the skin.

Authors:  I M Hadshiew; M S Eller; B A Gilchrest
Journal:  Age (Omaha)       Date:  1999-04

Review 7.  Dietary restrictions and cancer.

Authors:  R W Hart; A Turturro
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

8.  The effects of graded levels of calorie restriction: V. Impact of short term calorie and protein restriction on physical activity in the C57BL/6 mouse.

Authors:  Sharon E Mitchell; Camille Delville; Penelope Konstantopedos; Davina Derous; Cara L Green; Yingchun Wang; Jing-Dong J Han; Daniel E L Promislow; Alex Douglas; Luonan Chen; David Lusseau; John R Speakman
Journal:  Oncotarget       Date:  2016-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.